Related Experiment Video

Updated: Mar 20, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

6.3K

Women with Cirrhosis: Prevalence, Natural History, and Management

Jeanne-Marie Giard1, Norah A Terrault1

  • 1Division of Gastroenterology, Department of Medicine, University of California, San Francisco, 400 Parnassus Avenue, San Francisco, CA 94143, USA.

Gastroenterology Clinics of North America
|June 5, 2016
PubMed

Insights

Cirrhosis is less common in women, with distinct causes like hepatitis C and autoimmune liver disease. Women generally experience slower disease progression and lower risks of liver failure and cancer compared to men.

Area of Science:

  • Hepatology
  • Internal Medicine
  • Women's Health

Background:

  • Cirrhosis prevalence is lower in women than men, influenced by lower rates of hepatitis B, hepatitis C, and alcohol consumption.
  • Key causes of cirrhosis in women include hepatitis C, autoimmune liver disease, nonalcoholic steatohepatitis, and alcoholic liver disease.
  • Women with chronic liver diseases typically show a reduced risk of progression to cirrhosis, liver failure, and hepatocellular carcinoma compared to men.

Purpose of the Study:

  • To summarize the epidemiology and clinical characteristics of cirrhosis in women.
  • To highlight the specific etiological factors and disease progression in female patients.
  • To address the unique considerations for managing pregnancy in women with cirrhosis.

Main Methods:

  • Literature review and synthesis of existing epidemiological data.
  • Analysis of etiological factors contributing to cirrhosis in women.
  • Review of clinical outcomes and management strategies for cirrhosis in females.

Main Results:

  • Hepatitis C, autoimmune etiologies, NASH, and alcohol are primary causes of cirrhosis in women.
  • Women demonstrate a generally lower risk for progression to end-stage liver disease and hepatocellular carcinoma.
  • Pregnancy in women with cirrhosis is rare due to infertility but necessitates specialized medical care.

Conclusions:

  • Cirrhosis presents differently in women regarding prevalence, etiology, and disease progression.
  • Understanding these sex-specific differences is crucial for accurate diagnosis and management.
  • Specialized care is essential for the infrequent cases of pregnancy in women with cirrhosis.

Keywords:
Alcoholic Liver DiseaseCirrhosisHepatitis BHepatitis CNonalcoholic Fatty Liver DiseasePortal HypertensionPregnancyWomen's health

More Related Videos

Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension04:00

Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension

Published on: November 15, 2024

945
Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis06:26

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on: July 18, 2025

1.1K

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
731
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.2K
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
2.0K
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
1000
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.6K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
324